KIAA0284 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.059800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.668550E-01
Normal-vs-Stage2
6.592100E-02
Normal-vs-Stage3
4.860800E-01
Normal-vs-Stage4
1.035370E-01
Stage1-vs-Stage2
6.497800E-01
Stage1-vs-Stage3
7.372400E-01
Stage1-vs-Stage4
5.149200E-01
Stage2-vs-Stage3
4.037800E-01
Stage2-vs-Stage4
6.936200E-01
Stage3-vs-Stage4
4.710200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.875900E-02
Normal-vs-AfricanAmerican
2.812800E-01
Normal-vs-Asian
5.071700E-02
Caucasian-vs-AfricanAmerican
9.029400E-01
Caucasian-vs-Asian
2.735200E-01
AfricanAmerican-vs-Asian
5.140600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.180100E-02
Normal-vs-Female
1.075010E-01
Male-vs-Female
3.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.485200E-01
Normal-vs-Age(41-60Yrs)
4.227700E-02
Normal-vs-Age(61-80Yrs)
1.037210E-01
Normal-vs-Age(81-100Yrs)
4.289700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.560200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.881800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.791400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.187400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.379800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.689400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.059700E-02
Normal-vs-Daily Drinker
6.673900E-02
Normal-vs-Weekly Drinker
1.233380E-01
Normal-vs-Occasional Drinker
6.890000E-02
Normal-vs-Social Drinker
1.122400E-01
Non Drinker-vs-Daily Drinker
9.562400E-01
Non Drinker-vs-Weekly Drinker
5.606800E-01
Non Drinker-vs-Occasional Drinker
6.076200E-01
Non Drinker-vs-Social Drinker
6.162000E-01
Daily Drinker-vs-Weekly Drinker
5.607800E-01
Daily Drinker-vs-Occasional Drinker
5.973600E-01
Daily Drinker-vs-Social Drinker
6.106000E-01
Weekly Drinker-vs-Occasional Drinker
9.043200E-01
Weekly Drinker-vs-Social Drinker
9.398400E-01
Occasional Drinker-vs-Social Drinker
9.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.119560E-01
Normal-vs-Grade 2
4.540200E-02
Normal-vs-Grade 3
2.473700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.714000E-01
Grade 1-vs-Grade 3
7.453800E-02
Grade 1-vs-Grade 4
1.119560E-01
Grade 2-vs-Grade 3
2.909800E-01
Grade 2-vs-Grade 4
4.540200E-02
Grade 3-vs-Grade 4
2.473700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.256370E-01
Normal-vs-NonDiabetic
5.055900E-02
Diabetic-vs-NonDiabetic
7.334300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.534060E-02
Normal-vs-NoPancreatitis
7.652100E-02
Pancreatitis-vs-NoPancreatitis
3.833200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.562100E-02
Normal-vs-N1
7.580400E-02
N0-vs-N1
6.046000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.609790E-02
Normal-vs-TP53-NonMutant
2.058800E-01
TP53-Mutant-vs-TP53-NonMutant
2.569600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
